Rivaroxaban for treatment of venous thromboembolism in older adults

Consultant Pharmacist

Volumn 29, Issue 9, 2014, Pages 627-630

  Mitchell, Ardath P ^a   Conway, Susan E ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

Author keywords

Deep vein thrombosis; EINSTEIN study; Older adult; Pulmonary embolism; Rivaroxaban; Venous thromboembolism

Indexed keywords

PLACEBO; RIVAROXABAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; MORPHOLINE DERIVATIVE; THIOPHENE DERIVATIVE;

AGED; ARTICLE; BODY WEIGHT; CREATININE CLEARANCE; DRUG EFFICACY; DRUG SAFETY; GERIATRIC PATIENT; HUMAN; KIDNEY FAILURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); VENOUS THROMBOEMBOLISM; AGING; COMPLICATION; DRUG EFFECTS; KIDNEY; PATHOPHYSIOLOGY; PULMONARY EMBOLISM; RECURRENT DISEASE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; FACTOR XA INHIBITORS; HUMANS; KIDNEY; MORPHOLINES; PULMONARY EMBOLISM; RECURRENCE; RENAL INSUFFICIENCY; THIOPHENES; VENOUS THROMBOEMBOLISM;

EID: 84929941904     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2014.627     Document Type: Article

References (6)

1. Rivaroxaban [package insert]. Titusville, NJ: Janssen Pharmaceuticals; August 2013.
2. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107:Supp:I4-8.
3. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141:e44S-e88S.
4. The EINSTEIN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010;363:2499-510.
5. The EINSTEIN-PE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012;366:1287-97.
6. Romualdi E, Donadini MP, Ageno W. Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study. Expert Rev Cardiovasc Ther 2011;9:841-4.